Literature DB >> 23453359

Epidemiology and risk factors for oesophageal adenocarcinoma.

Côme Lepage1, Antoine Drouillard, Jean-Louis Jouve, Jean Faivre.   

Abstract

Oesophageal adenocarcinoma will soon cease to be a rare form of cancer for people born after 1940. In many Western countries, its incidence has increased more rapidly than other digestive cancers. Incidence started increasing in the Seventies in England and USA, 15 years later in Western Europe and Australia. The cumulative risk between the ages of 15 and 74 is particularly striking in the UK, with a tenfold increase in men and fivefold increase in women in little more than a single generation. Prognosis is poor with a 5-year relative survival rate of less than 10%. The main known risk factors are gastro-oesophageal reflux, obesity (predominantly mediated by intra-abdominal adipose tissues) and smoking. Barrett's oesophagus is a precancerous lesion, however, the risk of degeneration has been overestimated. In population-based studies the annual risk of adenocarcinoma varied between 0.12% and 0.14% and its incidence between 1.2 and 1.4 per 1000 person-years. Only 5% of subjects with Barrett's oesophagus die of oesophageal adenocarcinoma. On the basis of recent epidemiological data, new surveillance strategies should be developed. The purpose of this review is to focus on the epidemiology and risk factors of oesophageal adenocarcinoma.
Copyright © 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Barrett's oesophagus; Incidence; Oesophageal adenocarcinoma; Risk factors; Survival

Mesh:

Year:  2013        PMID: 23453359     DOI: 10.1016/j.dld.2012.12.020

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  28 in total

1.  Diallyl Disulfide Suppresses the Inflammation and Apoptosis Resistance Induced by DCA Through ROS and the NF-κB Signaling Pathway in Human Barrett's Epithelial Cells.

Authors:  Cheng Feng; Yumei Luo; Yuanyuan Nian; Dong Liu; Xiaoran Yin; Jing Wu; Jia Di; Rong Zhang; Jun Zhang
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

2.  Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival.

Authors:  Wenfeng Li; Zhengyang Xu; Junfeng Hong; Yunsheng Xu
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

Review 3.  Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-07-06       Impact factor: 8.262

4.  Overview of esophageal cancer.

Authors:  Ghulam Abbas; Mark Krasna
Journal:  Ann Cardiothorac Surg       Date:  2017-03

Review 5.  Androgens and esophageal cancer: What do we know?

Authors:  Olga A Sukocheva; Bin Li; Steven L Due; Damian J Hussey; David I Watson
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

6. 

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

Review 7.  The epidemiology, diagnosis, and treatment of Barrett's carcinoma.

Authors:  Joachim Labenz; Herbert Koop; Andrea Tannapfel; Ralf Kiesslich; Arnulf H Hölscher
Journal:  Dtsch Arztebl Int       Date:  2015-03-27       Impact factor: 5.594

Review 8.  Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Thomas M Runge; Julian A Abrams; Nicholas J Shaheen
Journal:  Gastroenterol Clin North Am       Date:  2015-04-09       Impact factor: 3.806

Review 9.  Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.

Authors:  Francisco Schlottmann; Daniela Molena; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

10.  ENDOSCOPIC TREATMENT OF ESOPHAGEAL NEOPLASIA: A DECADE OF EVOLUTION.

Authors:  Nicholas J Shaheen
Journal:  Trans Am Clin Climatol Assoc       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.